Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

September 01, 2006 (Vol. 26, No. 15)

ISPE's Role in Pharma Industry's Transition

Society Makes Changes to Comply with Revised Risk-based GMP Paradigm

  • The pharmaceutical industry is at the beginning of a transition period in which major technological changes may significantly affect the industry, according to Gert Moelgaard, chairman of the International Society for Pharmaceutical Engineers (ISPE) and vp at NNE (www.nne.biz.com). “Looking 10 years ahead, I believe you may find a ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.